May 13, 2019
Acerus first quarter 2019 revenue 33% up from last year’s same period
Acerus posts total revenues in Q1-2019 of $2.2 million, an increase of $0.5 millionor 33% compared to the first quarter of 2018 (“Q1-2018”).
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
May 13, 2019
Lilly gets fifth FDA approval for Cyramza
Eli Lilly’s Cyramza got its fifth FDA approval for in an advanced or metastatic cancer – this one for the second-line treatment of patients with hepatocellular carcinoma (HCC) who are AFP-High (AFP ≥400 ng/mL).
May 13, 2019
North America expected to provide high business for the atopicdermatitis market 2019-2024
Food allergy has been essentially highly debatable for decades in atopicdermatitis, with some common food, including milk, egg, and soy. Thereis a lot of literature which provides evidence that common foodexacerbate atopic dermatitis.
May 11, 2019
TransPerfect Life Sciences Simplifies CRA Site Visits with myTI 1.2 Mobile Trial Interactive App
TransPerfectLife Sciences, a leading provider of services and technologies tosupport global product development for the life sciences industry, hasreleased version 1.2 of myTI,the mobile application that enables real-time eTMF management andoversight for study teams on the go.
May 10, 2019
Teva launches generic Delzicol delayed-release capsules in the United States
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) todayannounced the launch of a generic version of Delzicol®1(mesalamine) delayed-release capsules, 400 mg, in the U.S.
May 10, 2019
Global oligonucleotide synthesis market could reach $2.9billion by 2024
Global oligonucleotide synthesis market is expected to reach $2.9billion by 2024, at a CAGR of 10.5% during the forecast period of 2019to 2024.
May 10, 2019
FDA lists Sunovion’s, PsychoGenics’s SEP-363856 as breakthrough therapy for the treatment of schizophrenia
FDA) has granted Breakthrough Therapy Designation forSEP-363856, a novel agent for the treatment of people with schizophrenia.
May 10, 2019
North America contract research organization (CRO) market expected to reach $ 30.7B
The North America contract research organization (CRO) market isexpected to reach US$ 30,730.1 Mn in 2025 from US$ 16,369.3 Mn in 2017.
May 10, 2019
Influenza Vaccines Market projected to exceed $6 Billion by 2025
The global influenza vaccines market size is expected to surpass USD 6billion by 2025.
May 10, 2019
BioSpecifics Technologies ends quarter with $4.4 million
BioSpecifics reported net income of $4.4 million for the first quarter 2019, compared to net income of $4.0 million, for the same period in 2018.